2seventy bio plucks Turnstone Biologics exec Bernstein to be new CMO
2seventy bio plucks Turnstone Biologics exec Bernstein to be new [...]
Improving RNA editing for genetic diseases by recruiting the body’s natural protein
Improving RNA editing for genetic diseases by recruiting the body’s [...]
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Roivant decants another Vant armed with Eisai blood cancer drug [...]
Roche, Lilly push back against CMS painting their Alzheimer’s meds with the same brush as Biogen’s Aduhelm
Roche, Lilly push back against CMS painting their Alzheimer’s meds [...]
ProQR shares plummet as eye disease treatment flops phase 2/3 pediatric trial
ProQR shares plummet as eye disease treatment flops phase 2/3 [...]
Cassava scores a win as FDA declines to intervene in petition to stop its Alzheimer’s drug trials
Cassava scores a win as FDA declines to intervene in [...]
Metacrine lays off half its staff, mainly researchers, and ditches more work to focus on IBD after NASH disaster
Metacrine lays off half its staff, mainly researchers, and ditches [...]
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund [...]
With approval in sight, ObsEva sells regional rights to women’s health drug for tiny upfront
With approval in sight, ObsEva sells regional rights to women’s [...]
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an interest in psilocybin
Vivocore combines InterVivo, Transpharmation to form neuroscience CRO with an [...]